| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |